AITechCrunch AI1h ago
Enveda secures $311M to bring more nature-derived AI drugs into
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Read full articleSource: TechCrunch AI · Opens in new tab